Hynion AS, (HYN) Fair Value & Analysis
Consumer Cyclical · NO · Market cap 14.7M NOK
Fair value as of: Jul 12, 2026
From 1 valuation models · updated 29 days ago
Below-average quality, currently priced close to our fair value.
What matters now
- The price sits above even our optimistic bull case (kr 0.0177). The favourable scenario is already priced in.
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 12, 2026.
How to read this chart
60‑month range kr 0.0162 – kr 5.89 · the kr 0.0196 price screens above the kr 0.0177 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 12, 2026.
Analysis
Hynion AS, (HYN) currently trades at kr 0.0196, while our model-based Fair Value estimate is kr 0.0177, implying the stock looks roughly 9.7% fairly valued today. The Quality Score stands at 22/100 (below-average quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Trailing-twelve-month revenue stands at 6.3M NOK. Revenue grew 75.5% year over year. It earns a return on equity of -83.7%. Fundamentals as of Jul 12, 2026
For context, the median of 10 Consumer Cyclical peers we cover trades at -24% fair-value upside, at -10%, HYN screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 1 models by family
Notify me when HYN reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
Figures from reported company fundamentals · as of Jul 12, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 28 · Market factors (momentum, volatility) 21
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Hynion AS, together with its subsidiaries, operates as a hydrogen fuel company in Norway and Sweden. It sells hydrogen fuels to personal vehicles, taxis, busses, and trucks through hydrogen refueling stations; and sells turn-key hydrogen refueling station. The company was formerly known as Hydrogenisk AS and changed its name to Hynion AS in September 2019.
Full company description
Hynion AS, together with its subsidiaries, operates as a hydrogen fuel company in Norway and Sweden. It sells hydrogen fuels to personal vehicles, taxis, busses, and trucks through hydrogen refueling stations; and sells turn-key hydrogen refueling station. The company was formerly known as Hydrogenisk AS and changed its name to Hynion AS in September 2019. Hynion AS was incorporated in 2019 and is based in Høvik, Norway.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2019 – FY2023 · reported fiscal years
Hynion AS, reported revenue of kr 4.6M in FY2023 versus kr 223K in FY2019, a compound +113.6%/yr. Reported net income was −kr 32.2M in FY2023.
Watch HYN: get an alert when its fair value changes →
Peer Group
Specialty Retail · 221 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Specialty Retail median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Specialty Retail stocks, each showing price versus our Fair Value estimate (as of Jul 12, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Casey's General Stores, Inc CASY | $827.04 | $405.44 | -51% |
| Williams-Sonoma, Inc WSM | $222.84 | $164.16 | -26% |
| Ulta Beauty, Inc ULTA | $479.57 | $488.39 | +2% |
| DICK'S Sporting Goods, Inc DKS | $208.89 | $181.10 | -13% |
| Best Buy Co BBY | $83.98 | $109.12 | +30% |
| China Tourism Group 601888 | ¥52.90 | ¥40.40 | -24% |
| Tractor Supply Company TSCO | $31.01 | $35.52 | +15% |
| Murphy USA Inc MUSA | $618.57 | $423.35 | -32% |
| Five Below, Inc FIVE | $197.71 | $117.29 | -41% |
| Taiwan Mobile Co 3045 | 110.50 TWD | 80.98 TWD | -27% |
Compare Hynion AS, with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Cyclical stocks →
Frequently asked questions
Is Hynion AS, (HYN) overvalued or undervalued?
What is the fair value of HYN?
What is the quality score of HYN?
What is the revenue of Hynion AS, (HYN)?
What is the net profit margin of HYN?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Hynion AS, and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.